Xermelo Tablet
Product Images NDC 70720-125

4 FDA label images from Tersera Therapeutics Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Xermelo (NDC 70720-125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tersera Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Xer00 0002 01)

Chemical Structure (Xer00 0002 01)
Chemical structure of telotristat ethyl, the active ingredient in Xermelo 250 mg oral tablets by TerSera Therapeutics LLC. The diagram shows the detailed molecular formula with aromatic rings, functional groups, and stereochemistry.*
FDA Label Image

Figure 1 (Xer00 0002 02)

Figure 1 (Xer00 0002 02)
A cumulative proportion of patients chart showing change in overall average bowel movement frequency from baseline. The x-axis represents change values from -8 to 4, with improvement toward negative and deterioration toward positive values. The y-axis shows cumulative proportion percentages from 0 to 100%. Two lines compare Placebo three times daily (dashed gray line) and Xermelo 250 mg three times daily (solid black line). The graph illustrates greater improvement in bowel movement frequency for Xermelo compared to placebo.*
FDA Label Image

Principal Display Panel (3x7 weekly pack)

Principal Display Panel (3x7 weekly pack)
The image shows the packaging label for Xermelo (telotristat ethyl) 250 mg tablets by TerSera Therapeutics LLC. It is a weekly pack containing 21 tablets for oral use. The label includes directions to open, storage instructions, and the NDC 70720-125-22. The design features the TerSera logo and colored stripes on the bottom.*
FDA Label Image

Principal Display Panel (28 Day Case Label)

Principal Display Panel (28 Day Case Label)
Box packaging label for Xermelo (telotristat ethyl) tablets, 250 mg per tablet, manufactured by TerSera Therapeutics LLC. The label states it is a 28-day case containing 84 tablets, with directions for storage and warnings for prescription use only. The design includes the product name, strength, manufacturer logo, and NDC 70720-125-85.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.